Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions

Pei‐Ni Jone(Northwestern University), Samuel R. Dominguez(Children's Hospital Colorado), Matthew Mulvahill(University of Colorado Anschutz Medical Campus), Heather Heizer, Mary P. Glodé, Marsha S. Anderson(Children's Hospital Colorado)
The Pediatric Infectious Disease Journal
February 16, 2018
Cited by 36


Related Papers